Carboplatin/pemetrexedLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2025卷 / 1期

关键词：

D O I：

10.1007/s40278-024-66527-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：115 / 115

相关论文

共 50 条

[31] Carboplatin/Nivolumab/PemetrexedLack of efficacy
Reactions Weekly, 2024, 2000 (1) : 99 - 99
[32] Cisplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1895 (1) : 139 - 139
[33] Carboplatin/nivolumab/pemetrexedLack of efficacy
Reactions Weekly, 2024, 1998 (1) : 135 - 135
[34] Pembrolizumab/carboplatin/pemetrexedLack of efficacy and fulminant type-1 diabetes: case report
Reactions Weekly, 2021, 1852 (1) : 358 - 358
[35] Cisplatin/pemetrexedLack of efficacy : case report
Reactions Weekly, 2023, 1944 (1) : 204 - 204
[36] Cisplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2024, 2034 (1) : 106 - 106
[37] Gefitinib/pemetrexedLack of efficacy : case report
Reactions Weekly, 2024, 2018 (1) : 215 - 215
[38] Cisplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1953 (1) : 147 - 147
[39] Cisplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1941 (1) : 145 - 145
[40] Nedaplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1919 (1) : 452 - 452

← 1 2 3 4 5 →